51655-56-2

Basic information

• Product Name: 3-BUTYL-1-HEPTANOL
• Synonyms: 3-BUTYL-1-HEPTANOL
• CAS NO: 51655-56-2
• Molecular Formula: C11H24O
• Molecular Weight: 172.31
• Mol File: 51655-56-2.mol

Chemical Properties

• Boiling Point: 123.8-124.7 °C(Press: 19 Torr)
• Appearance: /
• Density: 0.828±0.06 g/cm3(Predicted)
• PKA: 15.14±0.10(Predicted)
• CAS DataBase Reference: 3-BUTYL-1-HEPTANOL(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BUTYL-1-HEPTANOL(51655-56-2)
• EPA Substance Registry System: 3-BUTYL-1-HEPTANOL(51655-56-2)

Safety Data

• Hazardous Substances Data: 51655-56-2(Hazardous Substances Data)

Usage

Uses

Used in Chemical Synthesis:
3-Butyl-1-heptanol is used as a reagent in the preparation of branched acyl alkyl fluorens, which form a smectic A phase. This application is particularly relevant in the field of material science, where the smectic A phase is a liquid crystalline phase with potential uses in display technologies and other advanced materials.
Used in Fragrance Industry:
Due to its distinctive odor, 3-butyl-1-heptanol can be used as a fragrance ingredient in the perfumery and cosmetics industry. Its unique scent profile can contribute to the creation of various fragrances and scents for personal care products.
Used in Flavor Industry:
3-Butyl-1-heptanol may also find application in the flavor industry, where it can be used to enhance or modify the taste of various food and beverage products. Its ability to impart a specific flavor note can be valuable in the development of new and innovative flavors.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3-butyl-1-heptanol could potentially be utilized as a solvent or intermediate in the synthesis of various drugs and active pharmaceutical ingredients. Its chemical properties make it a versatile compound for use in the development of new medications.
Used in Research and Development:
3-Butyl-1-heptanol may also be employed in research and development settings, where it can be used as a model compound to study the properties and behavior of long-chain alcohols and their derivatives. This can contribute to the advancement of scientific knowledge and the development of new materials and applications.

Upstream product

• 75-21-8 oxirane 
• 80256-56-0 butyl-3 heptanoate d'ethyle 
• 502-56-7 nonanone-5 
• 80256-55-9 butyl-3 hydroxy-3 heptanoate d'ethyle 
• 72284-19-6 3-butylhept-2-eneoic acid ethyl ester 

Downstream Products

• 80256-86-6 2-(5-Butyl-nonyl)-9H-fluorene 
• 80256-74-2 5-Butyl-1-(9H-fluoren-2-yl)-nonan-1-one 

Relevant articles and documents

BRANCHED TAIL LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

The application relates to lipids of Formula (A), Formula (B) and Formula (1-1), and to lipid nanoparticles (empty or loaded LNPs) including such a lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Lipid nanoparticles further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.

LNP COMPOSITIONS COMPRISING MRNA THERAPEUTICS WITH EXTENDED HALF-LIFE

The disclosure features a polynucleotide encoding a polypeptide, which polynucleotide comprises: a 5'UTR described herein; a coding region comprising a payload and a stop element described herein; and a 3'UTR described herein, and LNP compositions comprising the same. The polynucleotides and/or LNP compositions of the present disclosure can: increase the level and/or activity of the payload by increasing the half-life and/or duration of expression of the polynucleotide encoding the payload or of the payload polypeptide. Also disclosed herein are methods of treating a disease or disorder in a subject using the LNP compositions of the present disclosure.

Synthetic method for gamma-dialkyl bromopropane

The invention discloses a synthetic method for gamma-dialkyl bromopropane. The method is characterized by comprising the following steps: step 1, in the presence of an alkali, a compound I and triethyl phosphonoacetate are subjected to a Horner-Wadsworth-Emmons reaction to form a compound II; step 2, the compound II and palladium on carbon are subjected to a hydrogenation reduction reaction to form a compound III; step 3, the compound III is subjected to a reduction reaction under the action of NaBH4 to form a compound IV; and step 4, the compound IV and a bromide are subjected to a substitution reaction to form the compound V. The method provided by the invention has the characteristics of having a short route, wide applicability, relatively mild reaction conditions, a high reaction yield, and low costs, and being suitable for industrial scale-up production.

RECHERCES SUR LES SUBSTANCES MESOMORPHES-IX; SMECTIQUES "FOURCHUS". ORGANISATION MOLECULAIRE DANS LES PHASES SMECTIQUES

The synthesis and the mesomorphic properties of new branched smectogenic A derivatives of fluorene are described.The observation that branched chain compounds from a smectic A phase allows conclusions to be drawn on molecular arrangements in smectic A layers.